(Medical University of South Carolina) Medical University of South Carolina (MUSC) investigators report that long-term expansion protocols for adoptive cancer immunotherapy do not compromise Th17 cells' effectiveness against large tumors, in the March 9, 2017 issue of JCI Insight. This finding is important because rapid expansion protocols that are used to produce sufficient CD8+ T cell numbers for adoptive cell therapy (ACT) degrade their effectiveness. These findings underscore that Th17 cell durability offers promise for next-generation ACT trials.
via NAIJA Society
http://ift.tt/2huhMvk
ADVERTISEMENT
THE CONTRIBUTION OF ERECTILE DYSFUNCTION ( Weak Penis erection), TO THE HIGH DIVORCE RATE .
Dr Ejiro Imuere This is a topic so many have shied away from addressing. But this topic is what we expected many online "re...
ADVERTISEMENT
-
Bella Shmurda By Vanguard News Nigerian singer, Abiola Ahmed Akinbiyi, popularly known as Bella Shmurda, has revealed that his mother to... -
Sam Larry And Mohbad By channelstv.com Since the news of Mohbad's passing, public attention has turned to Larry as the subject o...
No comments:
Post a Comment